Edaglitazone

DB06519InvestigationalSmall molecule

Investigated for use/treatment in diabetes mellitus type 2.

Chemical structure of Edaglitazone
Primary indication
Investigated for use/treatment in diabetes mellitus type 2.Curator reviewed
Formula / weight
C24H20N2O4S2 · 464.55 g/mol (avg)
Code names
BM-131258 · R-483

Resolves to

Compound
UNII8GKF7V499BCAS213411-83-7ChEMBLCHEMBL3990804
Structure
InChIKeyHAAXAFNSRADSMK-UHFFFAOYSA-NSMILESCC1=C(CCOC2=C3C=CSC3=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1
Targets
P37231PPARG

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Edaglitazone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In